Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.
Yves J L BodarHans VeermanDennie MeijerKatelijne de BiePim J van LeeuwenMaarten L DonswijkR Jeroen A van MoorselaarN Harry HendrikseRonald BoellaardDaniela E Oprea-LagerAndré N VisPublished in: BJU international (2022)
, may be a valuable innovative biomarker in patients with localised PCa, as it is highly associated with known conventional prognostic factors, such as pISUP and LN status.